Table 2. On-study HSR reaction characteristics.
HSR on study | |
---|---|
|
N=18 (%/range) |
Grade | |
1 | 6 (33.3) |
2 | 7 (38.9) |
3 |
5 (27.8) |
Symptoms | |
Pruritus | 16 (88.9) |
Rash | 14 (77.8) |
Chest tightness | 7 (38.9) |
Tachycardia | 6 (33.3) |
Flushing | 5 (27.8) |
Throat tightness | 5 (27.8) |
Nausea/vomiting | 4 (22.2) |
Hypotension | 4 (22.2) |
Angioedema | 4 (22.2) |
Dyspnea | 4 (22.2) |
Delayed reaction |
1 (5.6) |
Median carboplatin study cycle at time of initial HSR |
2 (1–5) |
Median cumulative carboplatin cycle at time of initial HSR |
11.5 (3–22) |
Outcome | |
Successfully continuing on study | 6 (33.3) |
Off carboplatin because of HSR | 5 (27.8) |
Off study for progression of disease | 5 (27.8) |
Off study for other reasons: | 2 (11.1) |
Elective withdrawal | 1 (5.6) |
Intolerable adverse effects | 1 (5.6) |
Abbreviation: HSR=hypersensitivity reaction.